Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Releases Early Stage Data For CRV431’s Research...

Max - 0

Curis, Inc. (NASDAQ:CRIS) Begins Phase 1 Clinical Trial Of CA-4948: Administers...

Max - 0

Anavex Life Sciences Corp (NASDAQ:AVXL) Commences Phase 1 Clinical Study Of...

Max - 0

Pulmatrix Inc. (NASDAQ:PULM) Partners with Sensory Cloud under a License Agreement...

Max - 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Partners with Medicago to Investigate and Evaluate...

Max - 0

AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Agrees to Financially Support Roswell Park Comprehensive...

Max - 0

Jaguar Health Inc. (NASDAQ:JAGX) Subsidiary Napo Pharmaceuticals Announces the Filing of...

Max - 0

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) Will Support a New Drug Application (NDA)...

Max - 0

Outlook Therapeutics Inc (NASDAQ:OTLK) Finalizes Patient Enrollment In Its NORSE 2...

Max - 0

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Clinches $450 Million Deal From The US...

Max - 0
1...215216217...248Page 216 of 248